University of California San Francisco
Give to UCSF
Cancer and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, might not seem to have much in common, but some researchers now are pinning hopes on the same immune system cell –
A community-led project to provide comprehensive COVID-19 testing to residents, essential workers, and first responders in the town of Bolinas has determined that all of the 1,845 nasal and oral swab tests conducted in the community between April 20 and April 24 were negative for active infection with the novel coronavirus SARS-CoV-2, which causes COVID-19.
An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19.
To ramp up contact tracing for COVID-19 in San Francisco, UCSF has been partnering with the San Francisco Department of Public Health (SFDPH) to provide technical assistance, training and manpower.
A new large-scale, long-term research collaboration aims to better understand the spread of COVID-19 across the San Francisco Bay Area.
The two from UCSF are among 120 new members elected to the Academy in 2020.
Paramedics transport a mock patient into UCSF’s Mount Zion medical center during a drill. Photo by Noah Berger UCSF Health has opened 13 acute- and critical-care beds at its Mount Zion hospital as
UCSF pediatrician and epidemiologist, Elena Fuentes-Afflick, MD, MPH, has been elected to the American Academy of Arts and Sciences, which honors exceptional scholars, leaders, artists and innovators. Fuentes-Afflick’s research has focused on the issues of acculturation, immigrant health and health disparities.
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
BRIDGE is an interface available to physicians during their encounter with patients.
As people around the world try to envision recovery from the COVID-19 pandemic, much attention has been paid to antibody testing as a way to identify people who have developed immunity to the virus. UCSF experts explain how antibody testing works, who it can be most useful for and why we should be cautious.
A UCSF researcher is among the team that announced promising Phase 1 clinical results for the first new oral polio vaccine in 50 years.
Marilyn Stebbins, a UCSF School of Pharmacy faculty member, shares a firsthand account of being a COVID-19 patient.
The UCSF health care workers specialize in critical care, intensive care, acute care and hospital medicine.
UCSF infectious disease researchers and community partners have launched an effort to provide comprehensive, voluntary COVID-19 testing to all residents of two distinctive Bay Area communities.
UCSF is recruiting newly diagnosed COVID-19 patients for a large global clinical trial testing whether the common anti-inflammatory drug colchicine can reduce hospitalization and death caused by the illness.
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
UCSF is announcing that it will provide free COVID-19 sample analysis, indefinitely, to all California Departments of Public Health.
